Signed, p. 5: Marco Lastri. Book.
0000 - Gale Group | The Making of Modern World
William R. Thelin, Mehmet Kesımer, Robert Tarran, Silvia M. Kreda, Barbara R. Grubb, John K. Sheehan, M. Jackson Stutts, Sharon L. Milgram,
... Peptides corresponding to residues 1375-1401, 1411-1441, 1451-1476, and 1471-1480 of human CFTR synthesized ... last 25 amino acids of CFTR (encompassing residues 1451-1476), which precede, but do not include, the ... interactions have been reported. We immobilized biotinylated CFTR-(1451-1476) peptides on streptavidin-agarose beads, incubated the ... serine/threonine protein phosphatase PP2A associated with CFTR-(1451-1476). PP2A dephosphorylates CFTR in vitro and decreases ... identify the PP2A regulatory subunits associated with CFTR-(1451-1476) as Aα and B′ϵ (Fig. 1B). ...
Tópico(s): Tracheal and airway disorders
2005 - Elsevier BV | Journal of Biological Chemistry
... analyses des pièces, nos l à 903:862-1451, 20 septembre.--II. nos 904 à 1678; 1451, 15 octobre-1544, 27 juin.--III. nos 1679 ...
0000 - Gale Group | MOMW2
... on the development and support of the IEEE 1451 Smart Transducer Interface Standard for Sensors and Actuators. ... provide reference implementations and applications of the IEEE 1451 family of standards. This paper describes an object-oriented application framework for the IEEE 1451.1 standard. This framework consists of four layers-the operating system, middleware and tools, the 1451.1 layer, and the application layer. The 1451.1 layer focuses on the class hierarchy of the IEEE 1451.1 standard. It consists of the neutral model ...
Tópico(s): Inertial Sensor and Navigation
2005 - Institute of Electrical and Electronics Engineers | IEEE Transactions on Instrumentation and Measurement
... analyses des pièces, nos l à 903:862-1451, 20 septembre.--II. nos 904 à 1678; 1451, 15 octobre-1544, 27 juin.--III. nos 1679 ...
0000 - Gale Group | MOMW2
Marta Marquié, Marc D. Normandin, Charles Vanderburg, Isabel Costantino, Elizabeth Bien, Lisa G. Rycyna, William E. Klunk, Chester A. Mathis, Miloš D. Ikonomović, Manik L. Debnath, Neil Vasdev, Bradford C. Dickerson, Stephen N. Gomperts, John H. Growdon, Keith A. Johnson, Matthew P. Frosch, Bradley T. Hyman, Teresa Gómez‐Isla,
... of positron emission tomography tracer [F-18]-AV-1451 (previously known as T807), tailored to allow in ... non-amyloid proteins.We applied [F-18]-AV-1451 phosphor screen autoradiography, [F-18]-AV-1451 nuclear emulsion autoradiography, and [H-3]-AV-1451 in vitro binding assays to the study of ... pathology.Our data suggest that [F-18]-AV-1451 strongly binds to tau lesions primarily made of ... α-synuclein, or TDP-43. [F-18]-AV-1451 off-target binding to neuromelanin- and melanin-containing ... identified.Our data suggest that [F-18]-AV-1451 holds promise as a surrogate marker for the ...
Tópico(s): Advanced Neuroimaging Techniques and Applications
2015 - Wiley | Annals of Neurology
... analyses des pièces, nos l à 903:862-1451, 20 septembre.--II. nos 904 à 1678; 1451, 15 octobre-1544, 27 juin.--III. nos 1679 ...
0000 - Gale Group | MOMW2
Allan K. Hansen, Karoline Knudsen, Thea P. Lillethorup, Anne M. Landau, Peter Parbo, Tatyana D. Fedorova, Hélène Audrain, Dirk Bender, Karen Østergaard, David J. Brooks, Per Borghammer,
The tau tangle ligand 18 F-AV-1451 ( 18 F-T807) binds to neuromelanin in the midbrain, and may therefore be a measure of the pigmented dopaminergic neuronal count in the ... We investigated the utility of 18 F-AV-1451 positron emission tomography to visualize the concentration of ... sex-matched control subjects had 18 F-AV-1451 positron emission tomography using a Siemens high-resolution ... disease displayed visually apparent decreased 18 F-AV-1451 signal in the midbrain. On quantitation, patients showed ... mean decrease in total nigral 18 F-AV-1451 volume of distribution compared with controls ( P = 0. ...
Tópico(s): Neurological disorders and treatments
2016 - Oxford University Press | Brain
... analyses des pièces, nos l à 903:862-1451, 20 septembre.--II. nos 904 à 1678; 1451, 15 octobre-1544, 27 juin.--III. nos 1679 ...
0000 - Gale Group | MOMW2
Jennifer L. Whitwell, Val J. Lowe, Nirubol Tosakulwong, Stephen D. Weigand, Matthew L. Senjem, Christopher G. Schwarz, Anthony J. Spychalla, Ronald C. Petersen, Clifford R. Jack, Keith A. Josephs,
Background The [18F]AV-1451 positron emission tomography ligand allows the in vivo assessment of tau proteins in the brain. It shows strong binding in ... this study were to determine whether [18F]AV-1451 uptake can be observed in progressive supranuclear palsy ... controls and Alzheimer's dementia. Methods [18F]AV-1451 positron emission tomography was performed in 10 patients ... dementia patients who had undergone identical [18F]AV-1451 imaging. Regional comparisons of [18F]AV-1451 uptake were performed across the whole brain using ...
Tópico(s): Neurological disorders and treatments
2016 - Wiley | Movement Disorders
Outsider, John Harold, J.W. Howlett,
... London Stock Markets Price Current (Continued from page 1451.) 42 1/2% Pittsburgh, Cincinnati, Chicago And St. ...
1893 - Gale Group | The Economist
Luca Passamonti, Patricia Vázquez Rodríguez, Young T. Hong, Kieren Allinson, David J. Williamson, Robin Borchert, Saber Sami, Thomas Cope, W Richard Bevan‐Jones, P. Simon Jones, Robert Arnold, Ajenthan Surendranathan, Elijah Mak, Li Su, Tim D. Fryer, Franklin I. Aigbirhio, John T. O’Brien, James B. Rowe,
... tau biomarkers. We assessed the radiotracer 18F-AV-1451 with positron emission tomography imaging to compare the ... groups, respectively. We also examined the 18F-AV-1451 autoradiographic binding in post-mortem tissue from patients ... a control case to assess the 18F-AV-1451 binding specificity to Alzheimer's and non-Alzheimer's tau pathology. There was increased 18F-AV-1451 binding in multiple regions in living patients with ... 5, P < 0.00001]. More specifically, 18F-AV-1451 binding was significantly increased in patients with Alzheimer' ...
Tópico(s): Dementia and Cognitive Impairment Research
2016 - Oxford University Press | Brain
... an Afghan dynasty who ruled over Delhi between 1451 and 1526 after the fall of the Sayyids. ...
0000 - Gale Group | NCCO Photography
Hanna Cho, Jae Yong Choi, Mi Song Hwang, Seung Ha Lee, Young Hoon Ryu, Myung Sik Lee, Chul Hyoung Lyoo,
... for progressive supranuclear palsy (PSP). 18 F‐AV‐1451, a radiotracer that binds to the pathological tau ... to investigate cortical and subcortical 18 F‐AV‐1451 binding patterns in patients with PSP. Methods We ... and subcortical binding patterns in 18 F‐AV‐1451 positron emission tomography (PET) studies with those of ... PD and PSP groups, subcortical 18 F‐AV‐1451 binding did not correlate with the severity of ... the PSP patients showed greater 18 F‐AV‐1451 binding in the putamen, globus pallidus, subthalamic nucleus, ...
Tópico(s): Alzheimer's disease research and treatments
2016 - Wiley | Movement Disorders
... in foreground) at the left. India Museum no. 1451. Received from Captain Lyon 7 February 1871. Duplicate ...
0000 - Gale Group | NCCO Photography
Val J. Lowe, Geoffry L. Curran, Ping Fang, Amanda M. Liesinger, Keith A. Josephs, Joseph E. Parisi, Kejal Kantarci, Bradley F. Boeve, Mukesh K. Pandey, Tyler J. Bruinsma, David S. Knopman, David T. Jones, Leonard Petrucelli, Casey Cook, Neill R. Graff‐Radford, Dennis W. Dickson, Ronald C. Petersen, Clifford R. Jack, Melissa E. Murray,
... is essential to determine the specificity of AV-1451 PET for tau in brain imaging by using ... neurodegenerative disorders to evaluate the specificity of AV-1451 binding for tau aggregates. Tissue samples were selected ... 43, and α-synuclein and compared to AV-1451 autoradiography on adjacent sections. AV-1451 preferentially localized to neurofibrillary tangles, with less binding ... and less mature tau. The strength of AV-1451 binding with respect to tau isoforms in various ... or 4R tau. Only minimal binding of AV-1451 to TAR DNA-binding protein-43 positive regions ...
Tópico(s): Parkinson's Disease Mechanisms and Treatments
2016 - Springer Science+Business Media | Acta Neuropathologica Communications
... amer. vetus., no. 24; and Vignaud, Americ Vespuce 1451-1512. no. 3. One of 10 photostat copies ...
0000 - Gale Group | Sabin Jan-Jun 2013
Tyler J. Bruinsma, Derek R. Johnson, Ping Fang, Matthew L. Senjem, Keith A. Josephs, Jennifer L. Whitwell, Bradley F. Boeve, Mukesh K. Pandey, Kejal Kantarci, David T. Jones, Prashanthi Vemuri, Melissa E. Murray, Jonathan Graff‐Radford, Christopher G. Schwarz, David S. Knopman, Ronald C. Petersen, Clifford R. Jack, Val J. Lowe,
AV-1451 is an imaging agent labeled with the positron-emitting radiolabel Fluorine-18. 18F-AV-1451 binds paired helical filament tau (PHF-tau), a ... Alzheimer’s disease. In our study of AV-1451 uptake in the brains of cognitively normal subjects, ... a meningioma with visually significant uptake of AV-1451. We initiated the present retrospective study to further examine cases of meningioma that underwent AV-1451 imaging. We searched the patient records of 650 patients who had undergone AV-1451 at our institution for the keyword “meningioma” to ...
Tópico(s): Neurofibromatosis and Schwannoma Cases
2017 - Springer Nature | Annals of Nuclear Medicine
... Charlotte. October 1938 to 1954. 6. 061-EA-1451. German. P.III.i. No.145. (Holland). 61. ...
1938 - Gale Group | ArchivesUnbound Holocaust Rare
Céline Vermeiren, Philippe Motté, Delphine Viot, Georges Mairet‐Coello, Jean‐Philippe Courade, Martin Citron, Joël Mercier, Jonas Hannestad, Michel Gillard,
Lilly/Avid's AV-1451 is one of the most advanced tau PET tracers in the clinic. Although results obtained in Alzheimer's disease patients ... regions. Moreover, accurate quantification of [18 F]AV-1451 uptake in Alzheimer's disease may not be ... to characterize the in vitro binding of AV-1451 to understand and identify potential off-target binding ... discrimination observed in PSP patients.[3 H]AV-1451 and AV-1451 were characterized in in vitro binding assays using ... s disease and PSP patients.[3 H]AV-1451 binds to multiple sites with nanomolar affinities in ...
Tópico(s): Alzheimer's disease research and treatments
2017 - Wiley | Movement Disorders